Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
135,9 USD | -0,75% | -3,05% | +7,90% |
Vakgebied
Aantal werknemers: 879
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 54 | 100,0 % | 288 | 100,0 % | +436,15% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
North America
71,9
%
| 46 | 86,3 % | 207 | 71,9 % | +346,54% |
Asia
27,8
%
| 7 | 12,6 % | 80 | 27,8 % | +1.080,01% |
Europe
0,3
%
| 1 | 1,1 % | 1 | 0,3 % | +61,94% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jan Mikkelsen
FOU | Founder | 65 | 01-09-06 |
Scott Smith
DFI | Director of Finance/CFO | 50 | 08-08-16 |
Stina Singel
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-05-20 |
Kennett Sprogøe
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-12-07 |
Chief Administrative Officer | 62 | 01-12-07 | |
Peter Rasmussen
AUD | Comptroller/Controller/Auditor | 55 | 01-03-14 |
Corporate Officer/Principal | 63 | 01-08-15 | |
General Counsel | 53 | 01-01-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jan Mikkelsen
FOU | Founder | 65 | 01-09-06 |
Albert Cha
CHM | Chairman | 51 | 01-11-14 |
General Counsel | 53 | 01-01-08 | |
Lisa Bright
BRD | Director/Board Member | 56 | 01-04-17 |
Lars Holtug
BRD | Director/Board Member | 66 | 02-11-18 |
William Fairey
BRD | Director/Board Member | 59 | 01-09-22 |
Siham Imani
BRD | Director/Board Member | 47 | 01-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 57 707 439 | 6 000 000 ( 10,40 %) | 0 | 10,40 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,90% | 7,82 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |
- Beurs
- Aandelen
- Koers ASND
- Onderneming Ascendis Pharma A/S